Tag Archives: Early

Human Sperm Stem Cells Grown in Lab, an Early Step Toward Infertility Treatment

Infertility affects one in seven men of reproductive age worldwide. One idea for treating male sterility is spermatogonial stem cell (SSC) therapy. In this approach, sperm stem cells in the testis are transferred to a test tube, cultured and nudged into becoming fully fledged sperm. However, a key bottleneck has been identifying just the right… Read More »

Can Early Exposure Fix Food Allergies?

SOURCES: Maria Garcia-Lloret, MD, associate professor of pediatrics, division of Pediatric Allergy and Immunology, UCLA Health; co-director, UCLA food allergy clinic. Erica Broido, Los Angeles. UCLA Health: “Spotlight on Food Allergies: Pediatrics Allergy and Immunology Care.” National Institute of Allergy and Infectious Diseases: “LEAP Study Results.” American Academy of Pediatrics News: “New guidelines detail use… Read More »

Study finds new medication can significantly block early stages of COVID-19 in engineered human tissues

By Ana Gajic An international team of researchers led by University of British Columbia and in collaboration with St. Michael’s Hospital has found a trial drug that effectively blocks the cellular door SARS-CoV-2 uses to infect its hosts. The findings, published today in Cell, hold promise as a treatment capable of stopping early infection of the novel… Read More »

Project makes early progress in trying to standardize SDOH data

As the healthcare industry looks to electronically capture, use and exchange social determinants of health data, an effort is underway to standardize medical codes to leverage SDOH information across care settings. The Gravity Project, which held its kickoff meeting last May, is a multi-stakeholder initiative whose goal is the standardization of key data elements necessary… Read More »

Allergan scores year-end FDA nod for CGRP migraine med Ubrelvy, plans early 2020 launch

The CGRP migraine prevention field already has three meds from Amgen, Eli Lilly and Teva vying for market share, and now Allergan has scored the first approval for an oral CGRP to treat migraines as they happen. Allergan’s Ubrelvy, formerly known as ubrogepant, passed FDA gatekeepers Monday, becoming the first oral CGRP drug for the acute treatment of… Read More »